Please turn JavaScript on
Find more feeds
Drug Development and Delivery icon

Drug Development and Delivery

Want to stay in touch with the latest updates from Drug Development and Delivery? That's easy! Just subscribe clicking the Follow button below, choose topics or keywords for filtering if you want to, and we send the news to your inbox, to your phone via push notifications or we put them on your personal page here on follow.it.

Reading your RSS feed has never been easier!

Website title: Drug Development & Delivery - The Latest Methods in Drug Development

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  1.09 / day

Message History

Nemera and SCHOTT Pharma deliver verified pen injector platform with sterile cartridge system
To support the industry shift from hospital to homecare including a more convenient drug administration for patients, Nemera, a world-leading provider of drug delivery device solutions and combination product services, and SCHOTT Pharma, a pioneer in drug containment solutions and delivery systems, have strengthened their partnership to provide pharmaceutical companies with a...

Read full story
Lonza and Engitix Announce License Agreement to Advance Targeted ADC Development
Basel, Switzerland, and London, UK – Lonza, a contract development and manufacturing organization (CDMO), and Engitix, a global leader in ECM-based drug discovery and development, today announced a licensing agreement to advance the development of antibody-drug conjugates (ADCs) and deliver life-changing therapies for patients with chronic diseases.


Read full story
Samsung Biologics announces all-cash offer to acquire PolyPeptide

INCHEON, South Korea, — Samsung Biologics has announced the launch of an all-cash public tender offer to acquire 100% of the fully diluted share capital of PolyPeptide Group AG, a leading global contract development and manufacturing organization (CDMO) specializing in peptide-based active pharmaceutical ingredients (APIs).

Under the terms of the offer, PolyPe...


Read full story
Jasper Therapeutics Announces Merger with Kira Pharmaceuticals

REDWOOD CITY, Calif. and CAMBRIDGE, Mass.– Jasper Therapeutics, Inc., today announced that Jasper has completed the acquisition of Kira Pharmaceuticals, a former Cayman limited company that was engaged in the design of complement therapies to treat immune-mediated diseases, in an all-stock transaction (together, the “Combined Company”). Concurrent with the ac...


Read full story
Eli Lilly Makes $2.8 Billion Neuropsychiatry Acquisition

Another major move from Lilly – this time putting real capital behind psychedelics as a legitimate mental health treatment class.

Why this matters:

Treatment-resistant depression remains one of the hardest-to-crack areas in psychiatry. AtaiBeckley’s DMT-based lead asset offers a fundamentally different mechanism to standard antidepressants, and Lilly’s backing g...


Read full story